Founders Capital Management (Texas)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.16K | Hold |
6
| – | – | ﹤0.01% | 401 |
|
|
2026
Q1 | $1.03K | Hold |
6
| – | – | ﹤0.01% | 372 |
|
|
2025
Q4 | $1.03K | Hold |
6
| – | – | ﹤0.01% | 382 |
|
|
2025
Q3 | $881 | Hold |
6
| – | – | ﹤0.01% | 370 |
|
|
2025
Q2 | $771 | Hold |
6
| – | – | ﹤0.01% | 360 |
|
|
2025
Q1 | $780 | Hold |
6
| – | – | ﹤0.01% | 347 |
|
|
2024
Q4 | $805 | Hold |
6
| – | – | ﹤0.01% | 343 |
|
|
2024
Q3 | $886 | Hold |
6
| – | – | ﹤0.01% | 350 |
|
|
2024
Q2 | $835 | Hold |
6
| – | – | ﹤0.01% | 351 |
|
|
2024
Q1 | $834 | Hold |
6
| – | – | ﹤0.01% | 339 |
|
|
2023
Q4 | $825 | Hold |
6
| – | – | ﹤0.01% | 364 |
|
|
2023
Q3 | $741 | Sell |
6
-300
| -98% | -$38.2K | ﹤0.01% | 384 |
|
|
2023
Q2 | $38.9K | Hold |
306
| – | – | 0.03% | 160 |
|
|
2023
Q1 | $40K | Sell |
306
-17,483
| -98% | -$2.29M | 0.03% | 154 |
|
|
2022
Q4 | $2.34M | Hold |
17,789
| – | – | 1.76% | 21 |
|
|
2022
Q3 | $2.08M | Sell |
17,789
-2,811
| -14% | -$349K | 1.7% | 22 |
|
|
2022
Q2 | $2.42M | Sell |
20,600
-2,205
| -10% | -$262K | 1.91% | 20 |
|
|
2022
Q1 | $3.48M | Hold |
22,805
| – | – | 2.23% | 17 |
|
|
2021
Q4 | $3.48M | Sell |
22,805
-116
| -0.5% | -$18K | 2.23% | 17 |
|
|
2021
Q3 | $3.71M | Sell |
22,921
-1,194
| -5% | -$201K | 2.54% | 12 |
|
|
2021
Q2 | $3.95M | Sell |
24,115
-290
| -1% | -$44.7K | 2.57% | 11 |
|
|
2021
Q1 | $3.67M | Buy |
24,405
+1,535
| +7% | +$244K | 2.62% | 16 |
|
|
2020
Q4 | $3.46M | Buy |
+22,870
| New | +$3.27M | 2.45% | 14 |
|
|
2020
Q1 | $433K | Hold |
4,020
| – | – | 0.45% | 32 |
|
|
2019
Q4 | $484K | Buy |
4,020
+749
| +23% | +$83.6K | 0.37% | 36 |
|
|
2019
Q3 | $325K | Buy |
3,271
+380
| +13% | +$39.8K | 0.26% | 44 |
|
|
2019
Q2 | $315K | Buy |
2,891
+480
| +20% | +$51.1K | 0.28% | 46 |
|
|
2019
Q1 | $270K | Buy |
2,411
+40
| +2% | +$4.39K | 0.25% | 49 |
|
|
2018
Q4 | $229K | Buy |
2,371
+80
| +3% | +$8.49K | 0.24% | 50 |
|
|
2018
Q3 | $279K | Buy |
2,291
+1,625
| +244% | +$191K | 0.23% | 55 |
|
|
2018
Q2 | $73K | Sell |
666
-774
| -54% | -$82.8K | 0.06% | 100 |
|
|
2018
Q1 | $154K | Hold |
1,440
| – | – | 0.13% | 84 |
|
|
2017
Q4 | $154K | Hold |
1,440
| – | – | 0.13% | 86 |
|
|
2017
Q3 | $160K | Sell |
1,440
-90
| -6% | -$9.62K | 0.13% | 89 |
|
|
2017
Q2 | $158K | Hold |
1,530
| – | – | 0.14% | 82 |
|
|
2017
Q1 | $150K | Buy |
+1,530
| New | +$146K | 0.13% | 87 |
|
Other funds holding IBB
CB
Founders Capital Management (Texas)'s IBB Position: Q2 2026 in Review
Founders Capital Management (Texas) held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 6 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #401.
Founders Capital Management (Texas) first reported a position in IBB in Q1 2017 and has held it in 36 quarters since. The position peaked at $3.95M in Q2 2021. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Founders Capital Management (Texas) held 6 shares of iShares Biotechnology ETF worth $1.16K as of Q2 2026.
- Founders Capital Management (Texas) left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #401 holding.
- Founders Capital Management (Texas) first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 36 quarters since.
- Founders Capital Management (Texas)'s iShares Biotechnology ETF position peaked at $3.95M in Q2 2021.
- 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.